Since January 2018 the EU project PANBioRA is developing a modular system for a comprehensive risk assessment of biomaterials. The instrument will be able to compare different biomaterials and help doctors to choose the best suited material for a patient before implantation. Another function of the system is the risk assessment of new biomaterials (synthesized or obtained by modification of known biomaterials), which might have unforeseeable interactions with the immune system.
Click here for original story, Risk assessment at nanoscale level: A closer look at the mimotope variation analysis
Source: Phys.org